Alterations in galectin-3 expression and distribution correlate with breast cancer progression: Functional analysis of galectin-3 in breast epithelial-endothelial interactions

American Journal of Pathology

Volumn 165, Issue 6, 2004, Pages 1931-1941

  Shekhar, Malathy P V ^a,b   Nangia Makker, Pratima ^a   Tait, Larry ^a   Miller, Fred ^a   Raz, Avraham ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KARMANOS CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GALECTIN 3; MESSENGER RNA; METALLOPROTEINASE; PROTEIN SUBUNIT;

ARTICLE; BINDING AFFINITY; BREAST CARCINOGENESIS; BREAST TUMOR; CANCER CELL CULTURE; CELL INTERACTION; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; ENDOTHELIUM CELL; EPITHELIUM CELL; HUMAN; HUMAN CELL; MORPHOLOGY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SENSITIVITY ANALYSIS; SERODIAGNOSIS; STROMA; UMBILICAL VEIN; XENOGRAFT;

EID: 9644269159     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63245-2     Document Type: Article

References (43)

1. Barondes SH, Cooper DN, Gitt MA, Leffler H: Galectins. Structure and function of a large family of animal lectins. J Biol Chem 1994, 269: 20807-20810
2. Raz A, Carmi P, Raz T, Hogan V, Mohamed A, Wolman SR: Molecular cloning and chromosomal mapping of a human galactoside-binding protein. Cancer Res 1991, 51:2173-2178
3. Sato S, Burdett I, Hughes RC: Secretion of the baby hamster kidney 30-kDa galactose-binding lectin from polarized and nonpolarized cells: a pathway independent of the endoplasmic reticulum-Golgi complex. Exp Cell Res 1993, 207:8-18
4. Hughes R: Mac-2: a versatile galactose-binding protein of mammalian tissues. Glycobiology 1994, 4:5-12
5. Sato S, Hughes RC: Binding specificity of a baby hamster kidney lectin for H type I and II chains, polylactosamine glycans, and appropriately glycosylated forms of laminin and fibronectin. J Biol Chem 1992, 267:6983-6990
6. Sato S, Hughes RC: Regulation of-secretion and surface expression of Mac-2, a galactoside-binding protein of macrophages. J Biol Chem 1994, 269:4424-4430
7. Van den Brule FA, Castronovo V: Laminin binding lectins during cancer invasion and metastasis. Lectins and Pathology. Edited by M Caron, AP Steve. Warsaw, Poland, Harwood Academic Publishers, 2000, pp 79-121
8. Kasai K, Hirabayashi J: Galectins: a family of animal lectins that decipher glycocodes. J Biochem (Tokyo) 1996, 119:1-8
9. Ochieng J, Fridman R, Nangia-Makker P, Kleiner DE, Liotta LA, Stetler-Stevenson WG, Raz A: Galectin-3 is a novel substrate for human matrix metalloproteinases-2 and -9. Biochemistry 1994, 33: 14109-14114
10. Herrmann J, Turck CW, Atchison RE, Huflejt ME, Poulter L, Gitt MA, Burlingame AL, Barondes SH, Leffler H: Primary structure of the soluble lactose binding lectin L-29 from rat and dog and interaction of its non-collagenous proline-, glycine-, tyrosine-rich sequence with bacterial and tissue collagenase. J Biol Chem 1993, 268:26704-26711
11. Nangia-Makker P, Akahani S, Bresalier R, Raz A: The role of galectin-3 in tumor metastasis. Lectins and Pathology. Edited by M Caron, AP Steve. Warsaw, Poland, Harwood Academic Publishers, 2000, pp 67-77
12. Irimura T, Matsushita Y, Sutton RC, Carralero D, Ohannesian DW, Cleary KR, Ota DM, Nicolson GL, Lotan R: Increased content of an endogenous lactose-binding lectin in human colorectal carcinoma progressed to metastatic stages. Cancer Res 1991, 51:387-393
13. Castronovo V, Van Den Brule FA, Jackers P, Clausse N, Liu FT, Gillet C, Sobel ME: Decreased expression of galectin-3 is associated with progression of human breast cancer. J Pathol 1996, 179:43-48
14. Lotz MM, Andrews Jr CW, Korzelius CA, Lee EC, Steele Jr GD, Clarke A, Mercurio AM: Decreased expression of Mac-2 (carbohydrate binding protein 35) and loss of its nuclear localization are associated with the neoplastic progression of colon carcinoma. Proc Natl Acad Sci USA 1993, 90:3466-3470
15. Pacis RA, Pilat MJ, Pienta KJ, Wojno K, Raz A, Hogan V, Cooper CR: Decreased galectin-3 expression in prostate cancer. Prostate 2000, 44:118-123
16. van den Brule FA, Berchuck A, Bast RC, Liu FT, Gillet C, Sobel ME, Castronovo V: Differential expression of the 67-kD laminin receptor and 31-kD human laminin-binding protein in human ovarian carcinomas. Eur J Cancer 1994, 30A: 1096-1099
17. Idikio H: Galectin-3 expression in human breast carcinoma: correlation with cancer histologiv grade. Int J Oncol 1998, 12:1287-1290
18. Nangia-Makker P, Honjo Y, Sarvis R, Akahani S, Hogan V, Pienta KJ, Raz A: Galectin-3 induces endothelial cell morphogenesis and angiogenesis. Am J Pathol 2000, 156:899-909
19. Shekhar MP, Werdell J, Tait L: Interaction with endothelial cells is a prerequisite for branching ductal-alveolar morphogenesis and hyperplasia of preneoplastic human breast epithelial cells: regulation by estrogen. Cancer Res 2000, 60:439-449
20. Basolo F, Elliott J, Tait L, Chen XQ, Maloney T, Russo IH, Pauley R, Momiki S, Caamano J, Klein-Szanto AJP: Transformation of human breast epithelial cells by c-Ha-ras oncogene. Mol Carcinog 1991, 4:25-35
21. Dawson PJ, Wolman SR, Tait L, Heppner GH, Miller FR: MCF10AT: a model for the evolution of cancer from proliferative breast disease. Am J Pathol 1996, 148:313-319
22. Shekhar MP, Nangia-Makker P, Wolman SR, Tait L, Heppner GH, Visscher DW: Direct action of estrogen on sequence of progression of human preneoplastic breast disease. Am J Pathol 1998, 152:1129-1132
23. Visscher DW, Nangia-Makker P, Heppner G, Shekhar PV: Tamoxifen suppresses histologic progression to atypia and DCIS in MCFIOAT xenografts, a model of early human breast cancer. Breast Cancer Res Treat 2001, 65:41-47
24. Miller FR, Santner SJ, Tait L, Dawson PJ: MCF10DCIS.com xenograft model of human comedo ductal carcinoma in situ. J Natl Cancer Inst 2000, 92:1185-1186
25. Nangia-Makker P, Hogan V, Honjo Y, Baccarini S, Tait L, Bresalier R, Raz A: Inhibition of human cancer cell growth and metastasis in nude mice by oral intake of modified citrus pectin. J Natl Cancer Inst 2002, 94:1854-1862
26. Lu Z, Friess H, Graber HU, Guo X, Schilling M, Zimmermann A, Korc M, Buchler MW: Presence of two signaling TGF-beta receptors in human pancreatic cancer correlates with advanced tumor stage. Dig Dis Sci 1997, 42:2054-2063
27. Guo XZ, Friess H, Maurer C, Berberat P, Tang WH, Zimmermann A, Naef M, Graber HU, Korc M, Buchler MW: KAI1 is unchanged in metastatic and nonmetastatic esophageal and gastric cancers. Cancer Res 1998, 58:753-758
28. Meromsky L, Lotan R, Raz A: Implications of endogenous tumor cell surface lectins as mediators of cellular interactions and lung colonization. Cancer Res 1986, 46:5270-5275
29. Castronovo V, Campo E, van den Brule FA, Claysmith AP, Cioce V, Liu FT, Fernandez PL, Sobel ME: Inverse modulation of steady-state messenger RNA levels of two non-integrin laminin-binding proteins in human colon carcinoma. J Natl Cancer Inst 1992, 84:1161-1169
30. Nangia-Makker P, Thompson E, Hogan C, Ochieng J, Raz A: Induction of tumorigenicity by galectin-3 in a non-tumorigenic human breast carcinoma cell line. Int J Oncol 1995, 7:1079-1087
31. Honjo Y, Nangia-Makker P, Inohara H, Raz A: Down regulation of galectin-3 suppresses tumorigenicity of human breast carcinoma cells. Clin Cancer Res 2001, 7:661-668
32. Meyer JS: Cell kinetics of histologic variants of in situ breast carcinoma. Breast Cancer Res Treat 1986, 7:171-180
33. Lagios MD, Westdahl PR, Margolin FR, Rose MR: Duct carcinoma in situ. Relationship of extent of noninvasive disease to the frequency of occult invasion, multicentricity, lymph node metastases, and short-term treatment failures. Cancer 1982, 50:1309-1314
34. Nangia-Makker P, Sarvis R, Visscher DW, Bailey-Penrod J, Raz A, Sarkar FH: Galectin-3 and L1 retrotransposons in human breast carcinomas. Breast Cancer Res Treat 1998, 49:171-183
35. Le Marer N, Hughes RC: Effects of the carbohydrate-binding protein galectin-3 on the invasiveness of human breast carcinoma cells. J Cell Physiol 1996, 168:51-58
36. Mehul B, Bawumia S, Hughes RC: Cross-linking of galectin 3, a galactose-binding protein of mammalian cells, by tissue-type transglutaminase. FEBS Lett 1995, 360:160-164
37. Ochieng J, Platt D, Tait L, Hogan V, Raz T, Carmi P, Raz A: Structure-function relationship of a recombinant human galactoside-binding protein. Biochemistry 1993, 32:4455-4460
38. Mehul B, Bawumia S, Martin SR, Hughes RC: Structure of baby hamster kidney carbohydrate-binding protein CBP30, an S-type animal lectin. J Biol Chem 1994, 269:18250-18258
39. Massa SM, Cooper DN, Leffler H, Barondes SH: L-29, an endogenous lectin, binds to glycoconjugate ligands with positive cooperativity. Biochemistry 1993, 32:260-267
40. John CM, Leffler H, Kahl-Knutsson B, Svensson I, Jarvis GA: Truncated galectin-3 inhibits tumor growth and metastasis in orthotopic nude mouse model of human breast cancer. Clin Cancer Res 2003, 9:2374-2383
41. Ochieng J, Green B, Evans S, James O, Warfield P: Modulation of biological functions of galectin-3 by matrix metalloproteases. Biochim Biophys Acta 1998, 1379:97-106
42. Ochieng J, Gerold M, Raz A: Dichotomy in the laminin binding properties of soluble and membrane bound human galactoside binding protein. Biochem Biophys Res Commun 1992, 186:1674-1680
43. Inohara H, Raz A: Effects of natural complex carbohydrate (citrus pectin) on murine melanoma cell properties related to galectin-3 functions. Glycoconj J 1994, 11:527-532